Sonnet Biotherapeutics Holdings Inc (SONN) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Sep 30 2025 to Sep 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sonnet Biotherapeutics Holdings Inc   (NASDAQ: SONN)


Sonnet Biotherapeutics Holdings Inc's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sonnet Biotherapeutics Holdings Inc's ROI in the fourth quarter of 2025?
Sonnet Biotherapeutics Holdings Inc recorded a cumulative net loss of $-16 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -804.17%.

Within the Healthcare sector 811 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 3647 to 4044.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter		 (Mar 31 2025)
II. Quarter		 (Dec 31 2024)
I. Quarter		 (Sep 30 2024)
IV. Quarter
Y / Y Investment Change TTM 50.34 % - -62.12 % -44.45 % -20.66 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 11 -3 1 0 0
Return On Investment (TTM) -804.17 % - -2150.86 % - -
SONN's Overall Ranking # 4044 # 3647 # 4040 # 4313 # 0
Seq. Investment Change TTM - - -50.12 % -6.49 % -6.1 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -16 -14 -13 -9 -7

SONN Company Profile >> Back to SONN Roi Comparisons >> See Annual SONN Return On Investment



Return On Investment SONN's Ranking
Within: No.
Industry # 391
Sector # 812
Overall # 4044

Return On Investment Statistics
High Average Low
-118.49 %
-2027.6 %
-13885.55 %
(Mar 31 2022)   (Mar 31 2023)







Financial Statements
Sonnet Biotherapeutics Holdings Inc's IV. Quarter Investments $ 11 Millions SONN's Balance sheet
Sonnet Biotherapeutics Holdings Inc's IV. Quarter Income $ -6 Millions Quarterly SONN's Income Statement
SONN's Income by Division See SONN's Income by Division


SONN Annual Return On Investment (Sep 30 2025)
2025		 (Sep 30 2024)
2024		 (Sep 30 2023)
2023		 (Sep 30 2022)
2022		 (Sep 30 2021)
2021
Total Investments in Millions 11 0 0 -2 22
Y / Y Investment Growth - - - - 524.49 %
Net Income in Millions -16 -7 -19 -30 -25
Y / Y Net Income Growth - - - - -
Annual Return On Investment -148.43 % - - - -112.08 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SONN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SONN's Competitors
Subscribers only: Roi for Sonnet Biotherapeutics Holdings Inc's Suppliers
Subscribers only: Return On Investment for SONN's Customers

Other Ratios
SONN's Roa SONN's Inventory Turnover Ratio SONN's Growth Rates SONN's Dividend Statistics
SONN's Profitability Ratios SONN's Asset Turnover Ratio SONN's Dividend Growth
SONN's Roe SONN's Valuation Ratios SONN's Financial Strength Ratios SONN's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector ROI

Date modified: 2026-08-29T07:16:11+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.